External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Forsberg, Jonathan Agner ^a,b,c   Wedin, Rikard ^c   Bauer, Henrik C F ^c   Hansen, Bjarne H ^d   Laitinen, Minna ^e   Trovik, Clement S ^f   Keller, Johnny Ø ^d   Boland, Patrick J ^g   Healey, John H ^g  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bayesian analysis; Postoperative survival; Prognostic model; Skeletal metastasis

Indexed keywords

ADULT; AGED; ARTICLE; BAYES THEOREM; BAYESIAN ESTIMATED TOOLS FOR SURVIVAL 12; BAYESIAN ESTIMATED TOOLS FOR SURVIVAL 3; BONE METASTASIS; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL DECISION MAKING; CONTROLLED STUDY; EXTERNAL VALIDITY; FEMALE; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SURVIVAL PREDICTION; SURVIVAL TIME; THEORETICAL MODEL; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; BAYES THEOREM; BONE NEOPLASMS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; MODELS, STATISTICAL; SCANDINAVIA; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84867741488     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-493     Document Type: Article

References (18)

1. Algan SM, Horowitz SM. Surgical treatment of pathologic hip lesions in patients with metastatic disease. Clin Orthop Relat Res 1996, (332):223-231.
2. Wedin R. Surgical treatment for pathologic fracture. Acta Orthop Scand Suppl 2001, 72(2p):1-29.
3. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. Prognostic factors and a scoring system for patients with skeletal metastasis. J Bone Joint Surg Br 2005, 87:698-703. 10.1302/0301-620X.87B5.15185, 15855375.
4. Forsberg JA, Eberhardt J, Boland PJ, Wedin R, Healey JH. Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network. PLoS One 2011, 6:e19956. 10.1371/journal.pone.0019956, 3094405, 21603644.
5. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 1995, 66:143-146. 10.3109/17453679508995508, 7740944.
6. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005, 30:2186-2191.
7. Hansen BH, Keller J, Laitinen M, Berg P, Skjeldal S, Trovik C, Nilsson J, Walloe A, Kalén A, Wedin R. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl 2004, 75:11-15. 10.1080/00016470410001708270, 15188660.
8. Chow E, Finkelstein JA, Coleman RE. Metastatic cancer to the bone. DeVita, Hellman, and Rosenberg's Cancer: Principles & practice of oncology 2008, 2510-2515. Philadelphia, PA: Lippincott Williams & Wilkins, DeVita VT, Lawrence TS, Rosenberg SA, Weinberg RA, DePinho RA.
9. Lin PP, Mirza AN, Lewis VO, Cannon CP, Tu SM, Tannir NM, Yasko AW. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am 2007, 89:1794-1801. 10.2106/JBJS.F.00603, 17671020.
10. Wedin R, Bauer HC, Wersall P. Failures after operation for skeletal metastatic lesions of long bones. Clin Orthop Relat Res 1999, (358):128-139.
11. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996, 32A:1135-1141.
12. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 1990, 15:1110-1113.
13. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of Chemotherapeutic Agents 1949, 196. New York: Columbia University Press, MacLeod CM, 1.
14. Yamashita T, Siemionow KB, Mroz TE, Podichetty V, Lieberman IH. A prospective analysis of prognostic factors in patients with spinal metastases: Use of the revised Tokuhashi score. Spine (Phila Pa 1976) 2010, 36:910-917.
15. Nathan SS, Healey JH, Mellano D, Hoang B, Lewis I, Morris CD, Athanasian EA, Boland PJ. Survival in patients operated on for pathologic fracture: Implications for end-of-life orthopedic care. J Clin Oncol 2005, 23:6072-6082. 10.1200/JCO.2005.08.104, 16135474.
16. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655. 10.1097/00000421-198212000-00014, 7165009.
17. Rubin DB, Schenker N. Multiple imputation in health-care databases: an overview and some applications. Stat Med 1991, 10:585-598. 10.1002/sim.4780100410, 2057657.
18. Pearl J. Introduction to probabilities, graphs, and causal models. Causality: models, reasoning, and inference 2009, 1-38. New York: Cambridge University Press, Pearl J.